Li Zhang, Md

This study tests whether adding chemotherapy (carboplatin and pemetrexed) to the targeted drug osimertinib helps people with advanced non-small cell lung cancer that has both EGFR and TP53 gene mutations live longer without the cancer growing. About 294 adults who have not had pr…